Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
49.18
-0.36 (-0.73%)
Streaming Delayed Price
Updated: 12:32 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
878,632
Open
49.25
Bid (Size)
49.17 (2)
Ask (Size)
49.18 (23)
Prev. Close
49.54
Today's Range
49.07 - 49.45
52wk Range
42.63 - 57.82
Shares Outstanding
1,250,690,553
Dividend Yield
3.87%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
What's Going On European Pharma Giant AstraZeneca Stock On Wednesday?
March 27, 2024
Japan approves AstraZeneca & Sanofi's Beyfortus for respiratory syncytial virus in neonates, infants, & children. Also, Truqap receives approval for unresectable or recurrent breast cancer. AstraZeneca...
Via
Benzinga
How Is The Market Feeling About Sanofi?
March 27, 2024
Via
Benzinga
Performance
YTD
-1.64%
-1.64%
1 Month
+2.03%
+2.03%
3 Month
-1.15%
-1.15%
6 Month
-7.23%
-7.23%
1 Year
-9.25%
-9.25%
More News
Read More
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
March 26, 2024
Via
Benzinga
To the Moon and Beyond: 7 Stocks With Cosmic Potential
March 14, 2024
Via
InvestorPlace
Passport to Profits: 7 Global Growth Gems to Diversify Your Holdings
March 13, 2024
Via
InvestorPlace
(SNY) - Analyzing Sanofi's Short Interest
March 08, 2024
Via
Benzinga
Why the dividend investor may take a look at NASDAQ:SNY.
February 14, 2024
Via
Chartmill
NASDAQ:SNY is an undervalued gem with solid fundamentals.
February 14, 2024
Via
Chartmill
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
Via
InvestorPlace
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
Via
Benzinga
3 Cash Cow Dividend Stocks for Outsized Income & Upside
February 27, 2024
Via
InvestorPlace
6 reasons to buy Teva Pharmaceuticals stock sooner than later
February 26, 2024
Via
MarketBeat
Topics
Lawsuit
Exposures
Financial
Legal
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
Via
InvestorPlace
Rapt Therapeutics Crashes 65% After Unexpected Liver Failure Sidelines Two Tests
February 20, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Cruising For A Bruising
February 18, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
February 16, 2024
Via
The Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Via
InvestorPlace
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
Via
InvestorPlace
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
Via
Benzinga
Novo Nordisk To Up Production Capacity As Parent Buys Catalent
February 05, 2024
Via
Investor's Business Daily
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
February 05, 2024
Via
Benzinga
Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets
February 03, 2024
Via
Talk Markets
Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today?
February 02, 2024
Via
Benzinga
Sanofi (SNY) Q4 2023 Earnings Call Transcript
February 01, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.